Alliance Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Alliance Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8% to $180,680,000. Profit margin reached -18%. Total operating expenses were $143,461,000.

Profit Margin

Alliance Pharma plc (LSE:APH.L): Profit margin
2014 43.53M 8.38M 19.26%
2015 48.34M 12.69M 26.25%
2016 97.49M 18.09M 18.56%
2017 103.31M 28.91M 27.98%
2018 118.20M 18.35M 15.53%
2019 135.63M 25.01M 18.44%
2020 129.80M 8.02M 6.18%
2021 163.20M 7.31M 4.48%
2022 167.41M 936K 0.56%
2023 180.68M -33.13M -18.34%

APH.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
180.68M167.41M163.20M129.80M135.63M118.20M103.31M97.49M48.34M43.53M
Cost of revenue
75.66M65.73M53.75M46.98M49.56M45.56M44.35M42.64M19.61M18.49M
Gross profit
105.01M101.68M109.45M82.81M86.07M72.64M58.96M54.84M28.73M25.04M
Operating exp.
Research and development
000074K131K169K91K12K0
Selling and marketing
0000000000
Total operating expenses
143.46M72.88M81.72M54.44M48.63M43.72M33.15M29.53M16.44M13.56M
Operating income
-38.44M10.56M21.57M27.14M35.62M23.66M30.17M25.61M16.96M11.17M
Other income (expenses), net
-10.35M-5.36M-3.41M-3.3M-4.55M-864K1.98M-3.39M2.9M-1.31M
Income before tax
-48.8M5.20M18.15M13.01M31.07M22.80M28.36M22.21M15.18M10.15M
Income tax expense
-15.66M4.27M10.83M4.98M6.06M4.44M-541K4.12M2.49M1.77M
Net income
-33.13M936K7.31M8.02M25.01M18.35M28.91M18.09M12.69M8.38M
Earnings per share
Basic EPS
-0.060.000.010.010.040.030.060.030.040.03
Diluted EPS
-0.060.000.010.010.040.030.060.030.040.03
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source